UCB's Global Corporate Website
Welcome to UCB in the United States

About UCB in the United States

UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases that have significant unmet needs. By putting people at the heart of everything we do, we enable people to live their best lives, delivering impactful solutions patients value.

At UCB, we come together every day to work, laser-focused, on a simple question: How will this create value for people living with severe diseases? Patient value is not just what we say, but how we live. It is our culture of care, embodied by our patient value strategy. That’s because how we do business – from discovery to development to delivery – has been transformed and redesigned around the patient and their individual experience. People are at the heart of everything we do. We consider the person, not just the disease, and the people who care for them. We aim to address their needs in ways that go beyond just medicine. By fulfilling our commitment, driving innovation, and providing patients with a meaningful experience, more impactful solutions are on the horizon.

From our U.S. headquarters in Atlanta, Georgia, to our global home in Belgium, UCB's approximately 8,600 employees are focused on delivering moments that matter for people living with severe diseases, now and into the future. In the U.S., our footprint spans from coast to coast, with U.S. sites focused on global clinical development in Raleigh, North Carolina; on policy in Washington, D.C.; and research supporting UCB's pipeline in Boston, Massachusetts and Seattle, Washington as well as Durham, North Carolina.

Our Atlanta headquarters focuses on the delivery of our innovative therapies, ensuring patients, caregivers, and their healthcare providers are supported and can access our solutions.

Discover More About Us

Innovation

Person touches screen selecting the word “innovation”
<nolink>

U.S. Leadership

Glass building with fountain in forefront
Leadership

90-Year History

280_ReproNOV14
History

Disease Areas

280_May2010-Catherine-EPI-HR
Disease areas

UCB is committed to these disease states globally.

Green Strategy

<nolink>